| http://www.w3.org/ns/prov#value | - t A. Hamburg, said she based her decision on studies concluding that the drug has not been shown to be safe or life-extending for women with breast cancer that has spread.Avastin will remain on the market to treat other types of cancer ??? colon, lung, kidney and brain ??? and doctors can choose to prescribe it off-label for breast cancer patients, but insurance companies may no longer cover the $
|
